Search This Blog

Thursday, November 7, 2019

Spectrum Pharmaceuticals EPS beats by $0.17

Spectrum Pharmaceuticals (NASDAQ:SPPI): Q3 Non-GAAP EPS of -$0.22; GAAP EPS of -$0.24 beats by $0.17.
Cash & equivalents of $252M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)